Terminalia petiolaris A.Cunn ex Benth. Extracts Have Antibacterial Activity and Potentiate Conventional Antibiotics against β-Lactam-Drug-Resistant Bacteria

Author:

Zai Muhammad Jawad12,Cheesman Matthew James3ORCID,Cock Ian Edwin12ORCID

Affiliation:

1. Centre for Planetary Health and Food Security, Griffith University, Brisbane, QLD 4111, Australia

2. School of Environment and Science, Griffith University, Brisbane, QLD 4111, Australia

3. School of Pharmacy and Medical Sciences, Griffith University, Southport, QLD 4222, Australia

Abstract

Terminalia petiolaris A. Cunn. Ex Benth. (genus: Terminalia, family: Combretaceae) is native to Australia. Terminalia spp. have traditionally been used to treat various ailments, including bacterial infections. Solvents of varying polarity were used to extract compounds from leaves of this species, and the extracts were tested against a panel of bacteria, including antibiotic-resistant strains. The methanolic and water extracts showed substantial inhibitory activity against several bacteria, including antibiotic-resistant strains in both disc diffusion and liquid dilution assays. Combining these extracts with selected conventional antibiotics enhanced the inhibition of bacterial growth for some combinations, while others showed no significant interaction. In total, two synergistic, twenty-five additive, twenty-three non-interactive and one antagonistic interaction were observed. The methanolic and ethyl acetate plant extracts were found to be non-toxic in Artemia franciscana nauplii toxicity assays. A liquid chromatography–mass spectrometry metabolomics analysis identified several flavonoid compounds, including miquelianin, trifolin and orientin, which might contribute to the observed activities. The potential modes of these active extracts are further discussed in this study.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference35 articles.

1. O’Neill, J. (2023, October 22). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance. Available online: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf.

2. World Health Organization (2021). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021.

3. D’Andrea, M.M., Fraziano, M., Thaller, M.C., and Rossolini, G.M. (2019). The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance. Antibiotics, 8.

4. Optimizing antibiotic therapies to reduce the risk of bacterial resistance;Bassetti;Eur. J. Intern. Med.,2022

5. UNICEF (2019). Levels and Trends in Child Mortality: Report 2019, World Bank Group. Available online: https://www.unicef.org/reports/levels-and-trends-child-mortality-report-2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3